Paper published in a journal (Scientific congresses and symposiums)
The comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: update of a real-world retrospective analysis
Reginster, Jean-Yves; Rizzoli, René; Cortet, Bernard et al.
2024In Aging Clinical and Experimental Research, 36 (S1), p. 4
Peer Reviewed verified by ORBi
 

Files


Full Text
WCO-IOF-ESCEO 2024 abstracts publiés Aging Clin Exp Res.pdf
Publisher postprint (44.06 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Public health, health care sciences & services
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Rizzoli, René
Cortet, Bernard
Wang, Y
Chiodo, J
Mitlak, B.H.
Language :
English
Title :
The comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: update of a real-world retrospective analysis
Publication date :
20 August 2024
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
IOF-ESCEO
Event date :
April 11-14 2024
By request :
Yes
Audience :
International
Journal title :
Aging Clinical and Experimental Research
ISSN :
1594-0667
eISSN :
1720-8319
Publisher :
Springer Science and Business Media LLC
Special issue title :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2024)
Volume :
36
Issue :
S1
Pages :
OC4
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 26 November 2024

Statistics


Number of views
11 (5 by ULiège)
Number of downloads
2 (1 by ULiège)

OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi